Archer Aviation (ACHR) Q3 2024 earnings summary

Executive summary

• Entering commercialization phase for eVTOL with regulatory momentum, including FAA's final powered-lift SFAR, providing a clear operational framework for rollout in the U.S. and internationally.

• Manufacturing facility in Georgia completed on time and on budget for $65M, with production to begin in early 2025 and ramp to two aircraft per month by year-end.

• Priority launch markets identified in the U.S. (New York, Los Angeles, San Francisco Bay Area, Miami) and internationally (UAE, Japan, India, Korea), with initial deployments and demonstration flights planned for 2025.

• Strategic partnerships with major airlines and regional operators, including United Airlines, Etihad, Falcon Aviation, and Japan Airlines/Soracle JV, supporting both demand and financing.

• Order book exceeds $6 billion, including pre-delivery payments and major international conditional orders.

Financial highlights

• Q3 2024 GAAP total operating expenses were $122.1M; non-GAAP total operating expenses were $96.8M after adjustments.

• Net loss for Q3 2024 was $115.3M (GAAP); Adjusted EBITDA was $(93.5)M.

• Cash and cash equivalents at Q3 2024 end: $501.7 million, the strongest position in 18 months.

• Net cash used in operating activities was $264.2 million for the nine months ended September 30, 2024; net cash provided by financing activities was $358.9 million.

• Research and development expenses rose 32.4% year-over-year to $89.8 million for Q3 2024.

Outlook and guidance

• Q4 2024 non-GAAP operating expenses expected to be $95–$110 million, reflecting increased engineering and manufacturing ramp.

• 2025 spend to focus on engineering, SG&A, supplier costs, labor, direct materials, and commercial operations, with core expenses expected flat to down.

• Majority of 2025 manufacturing labor and CapEx to be covered by Stellantis contract manufacturing agreement.

• Targeting production of 10 aircraft in 2025, ramping to two per month by year-end, with further increases in 2026.

• Management expects continued net losses and higher operating expenses as development, certification, and manufacturing scale up; existing cash is expected to fund operations for at least the next 12 months.